- Home
- RYOJ vs NTRB Comparison
RYOJ vs NTRB Comparison
Compare RYOJ & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RYOJ | NTRB |
|---|---|---|
| Founded | 2015 | 2016 |
| Country | Japan | United States |
| Employees | N/A | 3 |
| Industry | Professional Services | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.6M | 36.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RYOJ | NTRB |
|---|---|---|
| Price | $5.16 | $2.83 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 82.5K | 8.1K |
| Earning Date | 12-15-2025 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $30.17 |
| Revenue Next Year | N/A | $3,394.36 |
| P/E Ratio | $19.04 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.56 | $2.80 |
| 52 Week High | $11.43 | $8.63 |
Technical Indicators
Market Signals| Indicator | RYOJ | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 56.46 | 43.22 |
| Support Level | $3.39 | $2.91 |
| Resistance Level | $6.49 | $3.16 |
| Average True Range (ATR) | 0.74 | 0.11 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 46.81 | 31.95 |
Price Performance
Historical ComparisonAbout RYOJ rYojbaba Co. Ltd.
rYojbaba Co Ltd is engaged in improving and restoring physical and mental health diminished by work-related stress through consulting and health services. The company provides consulting services to labor unions and companies wishing to build constructive relationships with labor unions and health services to osteopathic clinics and osteopathic beauty salons to alleviate physical ailments created by work-related stress.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.